home

Company Snapshot

Read it, Learn it and Do it for your investment Needs
Daily market Tracker
Company News Details
Astrazeneca Pharma India Ltd
Pharmaceuticals - Multinational
BSE Code: 506820 NSE Symbol: ASTRAZEN P/E : 98.83
ISIN Demat: INE203A01020 Div & Yield %: 0.35 EPS : 92.47
Book Value: 319.60 Market Cap (Rs. Cr.): 22,845.88 Face Value : 2
AstraZeneca Pharma to launch Eculizumab (Soliris) in India Back
(06 Aug 2025)

 AstraZeneca Pharma India announced that it will launch Eculizumab (Soliris) in August 2025 in India.

Eculizumab (Soliris) is indicated for the treatment of patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) and atypical Hemolytic Uremic Syndrome (aHUS) to inhibit complement – mediated thrombotic microangiopathy.